Weapons Of Mass Feminization

• Who owns all these chemical, industrial companies that are messing our biology? Illuminists-Satanists. See documented evidence bottom of post.
  –
• Weapons Of Mass Feminization
  by Jennie Ann Freiman MD, http://www.greenmedinfo.com/
  If you’ve ever wondered where all the alpha males have gone, the interaction between chemistry and biology may offer a clue.
  –
  Gender bending chemicals are everywhere, literally impossible to avoid. They act as endocrine disruptors (EDs) that block, decrease, or overstimulate hormones. Most commonly, EDs mimic estrogen, lower testosterone and  prevent the male hormone from doing its job, causing males to exhibit more female traits. The resulting hormonal imbalances may be at the root  of disturbing worldwide trends for males that include delayed puberty, falling sperm counts, shrinking size of genitals, far fewer boys with far more genital deformities being born than ever before, and a rise in gender fluidity as boys are increasingly feminized. A similar effect is seen across the planet in wildlife, with reports of a rise in hermaphrodite amphibians, male fish developing eggs in their testicles and complete sex change in species with ED exposure. Governmental-industrial alliances have unleashed weapons of mass feminization throughout Planet Earth, involving all inhabitants in a dangerous and uncontrolled experiment whose results point to a dystopian future, the likes of which make Soylent Green look tame.
  –
  The NIH National Institute of Environmental Health Sciences says this about EDs:
  –
  Mass experimentation with hormones began early in the 20th century, but the term “endocrine disruptor” wasn’t coined until 1993:

• Diethylstilbestrol (DES), a synthetic estrogen, is the historical poster child for the effects of EDs. Early on it was used to lower testosterone levels in convicted sex offenders, a form of chemical castration. Doctors prescribed DES to an estimated 10 million pregnant women between the years 1938 – 1971. It strongly mimics estrogen and was thought to prevent miscarriage and other pregnancy problems. In 1947, the FDA eventually approved it for use in pregnancy. Research published in 1953 found that DES did not prevent miscarriage or premature birth, but doctors continued to prescribe it. In 1971, the FDA issued a Drug Bulletin instructing doctors to stop prescribing DES because it was found to cause a rare vaginal cancer in female offspring as young as 8 years old. DES sons are more likely to have testicular cysts, varicose veins, infection and inflammation, cryptorchidism (small and/or undescended testes), microphallus (small penis), hypospadias (malformed penis), infertility, and a higher prevalence of homosexuality, gender dysphoria, intersex conditions and identity as male to female transsexual or transgender.
  –
  read more.

end